MedPath

Analysis of Characteristics in Chronic Fatigue Patients through Pupillary Response and Eye Movement

Not Applicable
Conditions
Not Applicable
Registration Number
KCT0009682
Lead Sponsor
Dongguk University Bundang Oriental Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

(Experimental Group)
1. Adult men and women aged 19 to 60 years
2. Fatigue VAS score = 40
3. Individuals capable of normal communication
4. Individuals who have signed the informed consent form
(Control Group)
1. Adult men and women matching the experimental group in gender and age
2. Fatigue VAS score < 40
3. Individuals capable of normal communication
4. Individuals who have signed the informed consent form

Exclusion Criteria

1. Individuals with uncontrolled hypertension, edema, diabetes, or thyroid dysfunction
2. Individuals with tuberculosis, multiple sclerosis, or uncontrolled asthma
3. Individuals with major depressive disorder, bipolar disorder, schizophrenia, dementia, delusional disorder, claustrophobia, or panic disorder
4. Individuals with moderate or severe insomnia (PSQI = 15)
5. Individuals with a body mass index (BMI) less than 18.5 kg/m² or greater than 30 kg/m²
6. Pregnant or breastfeeding individuals
7. Individuals with a history of alcohol or substance abuse within the past three months
8. Individuals who have regularly consumed health supplements or products that may affect fatigue (such as health supplements or fatigue recovery products) within the past month
9. Heavy smokers (25 cigarettes/day or more)
10. Individuals with central nervous system damage, including stroke
11. Users of electronic devices worn inside the body, such as pacemakers
12. Users of life-supporting electronic medical devices, such as artificial heart-lung machines
13. Users of wearable electronic medical devices, such as ECG machines
14. Individuals with skin diseases (including trauma, bleeding, fractures, malignant tumors, eyelid, skull, oral and genital areas, or infectious diseases)
15. Individuals with photosensitivity or severe visual impairment (excluding those whose vision is corrected by lenses or who can write without glasses)
16. Any other individuals deemed unsuitable for participation by the researcher

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath